Praxis Precision Medicines, Inc.
PRAX
$346.84
$3.641.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 0.62% | 17.80% | |||
| Gross Profit | -0.62% | -17.80% | |||
| SG&A Expenses | 42.66% | 55.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.08% | 23.85% | |||
| Operating Income | -9.08% | -23.85% | |||
| Income Before Tax | -4.11% | -20.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.11% | -20.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.11% | -20.26% | |||
| EBIT | -9.08% | -23.85% | |||
| EBITDA | -9.08% | -23.84% | |||
| EPS Basic | 8.43% | -4.02% | |||
| Normalized Basic EPS | 11.36% | -8.22% | |||
| EPS Diluted | 8.43% | -4.02% | |||
| Normalized Diluted EPS | 11.36% | -8.22% | |||
| Average Basic Shares Outstanding | 13.68% | 15.61% | |||
| Average Diluted Shares Outstanding | 13.68% | 15.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||